Utilization of different MurNAc sources by the oral pathogen Tannerella forsythia and role of the inner membrane transporter AmpG.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
17 11 2020
Historique:
received: 27 05 2020
accepted: 12 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 4 8 2021
Statut: epublish

Résumé

The Gram-negative oral pathogen Tannerella forsythia strictly depends on the external supply of the essential bacterial cell wall sugar N-acetylmuramic acid (MurNAc) for survival because of the lack of the common MurNAc biosynthesis enzymes MurA/MurB. The bacterium thrives in a polymicrobial biofilm consortium and, thus, it is plausible that it procures MurNAc from MurNAc-containing peptidoglycan (PGN) fragments (muropeptides) released from cohabiting bacteria during natural PGN turnover or cell death. There is indirect evidence that in T. forsythia, an AmpG-like permease (Tanf_08365) is involved in cytoplasmic muropeptide uptake. In E. coli, AmpG is specific for the import of N-acetylglucosamine (GlcNAc)-anhydroMurNAc(-peptides) which are common PGN turnover products, with the disaccharide portion as a minimal requirement. Currently, it is unclear which natural, complex MurNAc sources T. forsythia can utilize and which role AmpG plays therein. We performed a screen of various putative MurNAc sources for T. forsythia mimicking the situation in the natural habitat and compared bacterial growth and cell morphology of the wild-type and a mutant lacking AmpG (T. forsythia ΔampG). We showed that supernatants of the oral biofilm bacteria Porphyromonas gingivalis and Fusobacterium nucleatum, and of E. coli ΔampG, as well as isolated PGN and defined PGN fragments obtained after enzymatic digestion, namely GlcNAc-anhydroMurNAc(-peptides) and GlcNAc-MurNAc(-peptides), could sustain growth of T. forsythia wild-type, while T. forsythia ΔampG suffered from growth inhibition. In supernatants of T. forsythia ΔampG, the presence of GlcNAc-anhMurNAc and, unexpectedly, also GlcNAc-MurNAc was revealed by tandem mass spectrometry analysis, indicating that both disaccharides are substrates of AmpG. The importance of AmpG in the utilization of PGN fragments as MurNAc source was substantiated by a significant ampG upregulation in T. forsythia cells cultivated with PGN, as determined by quantitative real-time PCR. Further, our results indicate that PGN-degrading amidase, lytic transglycosylase and muramidase activities in a T. forsythia cell extract are involved in PGN scavenging. T. forsythia metabolizes intact PGN as well as muropeptides released from various bacteria and the bacterium's inner membrane transporter AmpG is essential for growth on these MurNAc sources, and, contrary to the situation in E. coli, imports both, GlcNAc-anhMurNAc and GlcNAc-MurNAc fragments.

Sections du résumé

BACKGROUND
The Gram-negative oral pathogen Tannerella forsythia strictly depends on the external supply of the essential bacterial cell wall sugar N-acetylmuramic acid (MurNAc) for survival because of the lack of the common MurNAc biosynthesis enzymes MurA/MurB. The bacterium thrives in a polymicrobial biofilm consortium and, thus, it is plausible that it procures MurNAc from MurNAc-containing peptidoglycan (PGN) fragments (muropeptides) released from cohabiting bacteria during natural PGN turnover or cell death. There is indirect evidence that in T. forsythia, an AmpG-like permease (Tanf_08365) is involved in cytoplasmic muropeptide uptake. In E. coli, AmpG is specific for the import of N-acetylglucosamine (GlcNAc)-anhydroMurNAc(-peptides) which are common PGN turnover products, with the disaccharide portion as a minimal requirement. Currently, it is unclear which natural, complex MurNAc sources T. forsythia can utilize and which role AmpG plays therein.
RESULTS
We performed a screen of various putative MurNAc sources for T. forsythia mimicking the situation in the natural habitat and compared bacterial growth and cell morphology of the wild-type and a mutant lacking AmpG (T. forsythia ΔampG). We showed that supernatants of the oral biofilm bacteria Porphyromonas gingivalis and Fusobacterium nucleatum, and of E. coli ΔampG, as well as isolated PGN and defined PGN fragments obtained after enzymatic digestion, namely GlcNAc-anhydroMurNAc(-peptides) and GlcNAc-MurNAc(-peptides), could sustain growth of T. forsythia wild-type, while T. forsythia ΔampG suffered from growth inhibition. In supernatants of T. forsythia ΔampG, the presence of GlcNAc-anhMurNAc and, unexpectedly, also GlcNAc-MurNAc was revealed by tandem mass spectrometry analysis, indicating that both disaccharides are substrates of AmpG. The importance of AmpG in the utilization of PGN fragments as MurNAc source was substantiated by a significant ampG upregulation in T. forsythia cells cultivated with PGN, as determined by quantitative real-time PCR. Further, our results indicate that PGN-degrading amidase, lytic transglycosylase and muramidase activities in a T. forsythia cell extract are involved in PGN scavenging.
CONCLUSION
T. forsythia metabolizes intact PGN as well as muropeptides released from various bacteria and the bacterium's inner membrane transporter AmpG is essential for growth on these MurNAc sources, and, contrary to the situation in E. coli, imports both, GlcNAc-anhMurNAc and GlcNAc-MurNAc fragments.

Identifiants

pubmed: 33203363
doi: 10.1186/s12866-020-02006-z
pii: 10.1186/s12866-020-02006-z
pmc: PMC7670621
doi:

Substances chimiques

AmpG protein, Bacteria 0
Bacterial Proteins 0
Membrane Transport Proteins 0
Muramic Acids 0
Peptidoglycan 0
anhydro-N-acetylmuramic acid 0
N-acetylmuramic acid 246FXU111L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

352

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : MA2436/7-1
Organisme : Österreichische Forschungsförderungsgesellschaft
ID : P26836-B22
Organisme : Österreichische Forschungsförderungsgesellschaft
ID : I2875-B22
Organisme : Austrian Science Fund FWF
ID : I 2875
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : W 1224
Pays : Austria
Organisme : Österreichische Forschungsförderungsgesellschaft
ID : P27374-B22

Références

Front Microbiol. 2018 Jan 26;9:19
pubmed: 29434575
J Biol Chem. 2000 Dec 15;275(50):39032-8
pubmed: 10978324
J Clin Periodontol. 1998 Feb;25(2):134-44
pubmed: 9495612
Bacteriol Rev. 1972 Dec;36(4):407-77
pubmed: 4568761
Int J Med Microbiol. 2019 Nov;309(7):151326
pubmed: 31296364
Environ Microbiol. 2015 Nov;17(11):4394-405
pubmed: 25845735
J Bacteriol. 2010 Jun;192(12):3132-43
pubmed: 20400549
J Bacteriol. 1975 Dec;124(3):1067-76
pubmed: 357
Sci Adv. 2019 Jan 23;5(1):eaau3333
pubmed: 30746447
J Bacteriol. 2016 Oct 21;198(22):3119-3125
pubmed: 27601356
FEMS Microbiol Lett. 2011 May;318(2):189-96
pubmed: 21385202
Int J Oral Sci. 2011 Apr;3(2):49-54
pubmed: 21485308
Infect Immun. 1989 Jun;57(6):1757-9
pubmed: 2722237
Beilstein J Org Chem. 2017 Dec 11;13:2631-2636
pubmed: 30018663
EMBO J. 1994 Oct 3;13(19):4684-94
pubmed: 7925310
J Bacteriol. 2002 Dec;184(23):6434-6
pubmed: 12426329
Mol Oral Microbiol. 2014 Dec;29(6):307-20
pubmed: 24943676
Biotechnol Lett. 2006 Jan;28(1):55-9
pubmed: 16369876
J Clin Periodontol. 2017 Mar;44 Suppl 18:S12-S22
pubmed: 28266111
J Bacteriol. 2007 Aug;189(15):5634-41
pubmed: 17526703
Front Microbiol. 2017 Apr 12;8:648
pubmed: 28446907
Nat Rev Immunol. 2015 Jan;15(1):30-44
pubmed: 25534621
J Bacteriol. 2009 Jan;191(2):494-505
pubmed: 18996994
Infect Immun. 1982 Apr;36(1):114-22
pubmed: 7076290
FEMS Microbiol Rev. 2008 Mar;32(2):149-67
pubmed: 18194336
J Bacteriol. 2005 Jun;187(11):3643-9
pubmed: 15901686
Antimicrob Agents Chemother. 2011 May;55(5):1990-6
pubmed: 21357303
Trends Biotechnol. 2019 Jul;37(7):761-774
pubmed: 30654913
Biochim Biophys Acta. 2008 Sep;1778(9):1714-34
pubmed: 17658458
J Dent Res. 2018 May;97(5):501-507
pubmed: 29342371
J Bacteriol. 2009 Apr;191(7):2012-22
pubmed: 19074387
Periodontol 2000. 2006;42:88-113
pubmed: 16930308
Ann N Y Acad Sci. 2013 Jan;1277:54-75
pubmed: 23163477
J Vis Exp. 2014 Jan 15;(83):e51183
pubmed: 24457605
Infect Immun. 1979 Sep;25(3):775-80
pubmed: 500186
ACS Chem Biol. 2016 Sep 16;11(9):2626-35
pubmed: 27442597
J Bacteriol. 2008 Jun;190(11):3799-807
pubmed: 18390650
Microb Pathog. 2007 Apr;42(4):156-66
pubmed: 17363213
Trends Mol Med. 2015 Mar;21(3):172-83
pubmed: 25498392
Trends Microbiol. 2010 Feb;18(2):59-66
pubmed: 20060721
Genome Announc. 2015 Jun 11;3(3):
pubmed: 26067981
BMC Microbiol. 2019 Sep 2;19(1):200
pubmed: 31477019
Aust Dent J. 2009 Sep;54 Suppl 1:S62-9
pubmed: 19737269
Microb Drug Resist. 2014 Jun;20(3):231-7
pubmed: 24819062
Periodontol 2000. 2005;38:72-122
pubmed: 15853938

Auteurs

Valentina M T Mayer (VMT)

Department of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria.

Markus B Tomek (MB)

Department of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria.

Rudolf Figl (R)

Department of Chemistry, Institute of Biochemistry, Universität für Bodenkultur Wien, Vienna, Austria.

Marina Borisova (M)

Department of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany.

Isabel Hottmann (I)

Department of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany.

Markus Blaukopf (M)

Department of Chemistry, Institute of Organic Chemistry, Universität für Bodenkultur Wien, Vienna, Austria.

Friedrich Altmann (F)

Department of Chemistry, Institute of Biochemistry, Universität für Bodenkultur Wien, Vienna, Austria.

Christoph Mayer (C)

Department of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany. christoph.mayer@uni-tuebingen.de.

Christina Schäffer (C)

Department of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria. christina.schaeffer@boku.ac.at.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Organoids Humans Tissue Engineering Coculture Techniques Regenerative Medicine
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Female Biofilms Animals Lactobacillus Mice

Classifications MeSH